Marta Monjo, PhD
Chief Scientific Officer and co-founder of NuMat Medtech.
Marta holds a MSc in Biology and MSc in Biochemistry and earned her PhD from the University of the Balearic Islands, where she currently teaches as Professor.
She was co-funder and part of the executive commission of BIOIB (the Biotechnology and Biomedical Cluster of the Balearic Islands) since its foundation in January 2010 until September 2013. She was partner of Corticalis AS (Norway) from 2008 to 2015.
She is the principal investigator of the ‘Cell Therapy and Tissue Engineering’ (TERCIT) research group. Her research has resulted in the publication of more than 70 research articles, more than 80 presentations to national and international conferences and 4 patents. She has participated in 21 R&D projects (10 as main investigator) and in 17 contracts with companies.
At NuMat Biomedical she served as Chief Executive Officer from 2008 to 2013, and as Chief Scientific Officer from 2014 to 2016.